Sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC): Updated results from a phase I/II study

被引：0
|
作者：
Redman, B. G.
Hudes, G. R.
Kim, S. T.
Chen, I.
Motzer, R. J.
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[3] Pfizer Global Res & Dev, La Jolla, CA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16014
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of sunitinib malate in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Patel, P. H.
    Kondagunta, G. V.
    Redman, B. G.
    Hudes, G. R.
    Kim, S. T.
    Chen, I.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Redman, B. G.
    Hudes, G. R.
    Kondagunta, G. V.
    Patel, P. H.
    Kim, S. T.
    Chen, I.
    Motzer, R. J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 302 - 302
  • [3] A phase I study of sunitinib malate (SU11248) in combination with gefitinib in patients with metastatic renal cell carcinoma (mRCC).
    Ronnen, E. A.
    Kondagunta, G. V.
    Lau, C.
    Fischer, P.
    Ginsberg, M. S.
    Baum, M.
    Kim, S. T.
    Chen, I.
    Baum, C. M.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 225S - 225S
  • [4] A phase II study of intermittent sunitinib in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC).
    Wood, Laura S.
    Dreicer, Robert
    Garcia, Jorge A.
    Gilligan, Timothy D.
    Ali, Khaled B.
    Haddad, Housam
    Shah, Shetal N.
    Elson, Paul
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Feldman, D. R.
    Kondagunta, G. V.
    Ronnen, E. A.
    Fischer, P.
    Chang, R.
    Baum, M.
    Ginsberg, M. S.
    Ishill, N.
    Patil, S.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Sunitinib therapy for patients (pts) with metastatic renal cell carcinoma (mRCC): Updated results of two phase II trials and prognostic factor analysis for survival
    Rosenberg, J. E.
    Motzer, R. J.
    Michaelson, M. D.
    Redman, B. G.
    Hudes, G. R.
    Bukowski, R. M.
    George, D. J.
    Kim, S. T.
    Baum, C. M.
    Wilding, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] A phase II study of intermittent sunitinib (S) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC)
    Rini, Brian I.
    Wood, Laura S.
    Elson, Paul
    Zhu, Hui
    Chittoria, Namita
    Mittal, Kriti
    Dreicer, Robert
    Gilligan, Timothy D.
    Shah, Shetal N.
    Garcia, Jorge A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Phase I/II Trial of Sunitinib Plus Gefitinib in Patients With Metastatic Renal Cell Carcinoma
    Motzer, Robert J.
    Hudes, Gary R.
    Ginsberg, Michelle S.
    Baum, Michael S.
    Harmon, Charles S.
    Kim, Sindy T.
    Chen, Isan
    Redman, Bruce G.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 614 - 618
  • [9] Continuous daily administration of sunitinib in patients (pts) with cytokine-refractory metastatic renal cell carcinoma (mRCC): Updated results
    Srinivas, S.
    Roigas, J.
    Gillessen, S.
    Harmenberg, U.
    De Mulder, P. H.
    Fountzilas, G.
    Vogelzang, N.
    Peschel, C.
    Flodgren, P.
    Escudier, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
    Tomita, Yoshihiko
    Shinohara, Nobuo
    Yuasa, Takeshi
    Fujimoto, Hiroyuki
    Niwakawa, Masashi
    Mugiya, Soichi
    Miki, Tsuneharu
    Uemura, Hirotsugu
    Nonomura, Norio
    Takahashi, Masayuki
    Hasegawa, Yoshihiro
    Agata, Naoki
    Houk, Brett
    Naito, Seiji
    Akaza, Hideyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (12) : 1166 - 1172
12345